These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3524883)

  • 1. Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae.
    Gill HK; Mustafa AS; Godal T
    Bull World Health Organ; 1986; 64(1):121-6. PubMed ID: 3524883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals.
    Smelt AH; Rees RJ; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):501-6. PubMed ID: 7035030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro proliferation of lymphocytes from human volunteers vaccinated with armadillo-derived, killed M. leprae.
    Gill HK; Mustafa AS; Godal T
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):30-5. PubMed ID: 3549938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction.
    Gill HK; Mustafa AS; Godal T
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):36-44. PubMed ID: 3286799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitization studies with potential leprosy vaccine preparations in northern Malawi.
    Ponnighaus JM; Fine PE
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):25-37. PubMed ID: 3519803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine.
    Bull Pan Am Health Organ; 1986; 20(1):88-92. PubMed ID: 3533193
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress in the preparation of an antileprosy vaccine from armadillo-derived Mycobacterium leprae.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):515-8. PubMed ID: 6368415
    [No Abstract]   [Full Text] [Related]  

  • 11. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL; Ramanathan VD; Gupte MD
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte response of leprosy patients to human-derived and purified armadillo-derived Mycobacterium leprae, BCG and PPD.
    Smelt AH; Liew FY; Rees RJ
    Clin Exp Immunol; 1978 Nov; 34(2):164-9. PubMed ID: 367652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune responses to M. leprae in human volunteers vaccinated with killed, armadillo-derived M. leprae.
    Gill HK; Mustafa AS; Ivanyi J; Harboe M; Godal T
    Lepr Rev; 1986 Dec; 57 Suppl 2():293-300. PubMed ID: 3553802
    [No Abstract]   [Full Text] [Related]  

  • 14. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ; Meyers WM
    Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.
    Fine PE; Gruer PJ; Maine N; Ponnighaus JM; Rees RJ; Stanford JL
    Clin Exp Immunol; 1989 Aug; 77(2):226-9. PubMed ID: 2673590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationales for vaccines against leprosy.
    Bloom BR
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):505-9. PubMed ID: 6368414
    [No Abstract]   [Full Text] [Related]  

  • 18. Animal vaccination studies with Mycobacterium leprae.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):519-23. PubMed ID: 6368416
    [No Abstract]   [Full Text] [Related]  

  • 19. Sensitization and reactogenicity of two doses of candidate antileprosy vaccine Mycobacterium w.
    Gupte MD; Vallishayee RS; Anantharaman DS; Britto RL; Nagaraju B
    Indian J Lepr; 1996; 68(4):315-24. PubMed ID: 9001899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.